Brief: IGC Reports Qtrly Loss Per Share Of $0.05

IGC Pharma

19/08/2020 21:43

Aug 19 (Reuters) - India Globalization Capital Inc  IGC.A :
    * IGC REPORTS FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE
30,
2020 WHILE PREPARING FOR ITS FDA-APPROVED CANNABINOID CLINICAL
TRIALS ON ALZHEIMER’S PATIENTS
    * QUARTERLY LOSS PER SHARE $0.05

Source text for Eikon:  ID:nBw2G2MDra 
Further company coverage:  IGC.A 

 ((Reuters.Briefs@thomsonreuters.com;))